Safinamide: A new add-on drug for the treatment of Parkinson's disease
Journal Title: JOURNAL OF MEDICAL COLLEGE CHANDIGARH - Year 2017, Vol 7, Issue 2
Abstract
Safinamide is a new drug approved for the treatment of Parkinson's disease as an add-on therapy for the patients, who are taking levodopa and carbidopa and are experiencing 'off ' episodes. It has multiple modes of action including reversible inhibition of MAO-B enzyme and modulation of glutamate release. The drug increases the 'on' time and reduces the symptoms of Parkinson's disease without producing troublesome dyskinesia.
Authors and Affiliations
Sangeeta Bhanwra, Rajiv Kumar
Keywords
Related Articles
- EP ID EP312495
- DOI -
- Views 126
- Downloads 0
Recent advances in drug therapy of hyperlipoprotenemias
Not available
Ethics and research
Not available
Intracapsular dissection in cervical sympathetic chain schwannoma: a case report
Cervical sympathetic chain schwannoma often presents as an asymptomatic single neck mass, which generally grows slowly and rarely undergoes malignant change. Definitive pre-operative diagnosis at times may become difficu...
Catastrophic antiphospholipid syndrome presenting as coronary, cerebral and renal vascular thrombosis: A case report and review of literature
Catastrophic antiphospholipid syndrome (CAPS) is a rare life-threatening disorder characterized by diffuse vascular thrombosis. It can manifest as microangiopathy, involving small vessels and is associated with presence...
Dermatomyositis overlapping with Rheumatoid arthritis: a rare clinical entity
The association of dermatomyositis with rheumatoid arthritis (RA) is described in a 46 year old patient who was studied over a period of one year. Our patient had both diseases simultaneously overlapping with each other....